Inneke Wynant

Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin

Sandra De Jonghe, Jim Proctor, Petra Vinken et al. · Chemico-Biological Interactions · 2014 · 54 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity

Johan Monbaliu, Martha Gonzalez, Apexa Bernard et al. · Drug Metabolism and Disposition · 2016 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment

Sivi Ouwerkerk‐Mahadevan, Maria Beumont‐Mauviel, Steven Mortier et al. · Drugs in R&D · 2015 · 22 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Prediction of the drug–drug interaction potential of the α1‐acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib

Loeckie De Zwart, Jan Snoeys, Frank Jacobs et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 15 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor

Ellen Scheers, Carine Borgmans, Chi Keung et al. · Xenobiotica · 2020 · 12 citations

Pharmacy, Pharmacokinetics, Pharmacology +17